Literature DB >> 10712363

Fine mapping of PPH1, a gene for familial primary pulmonary hypertension, to a 3-cM region on chromosome 2q33.

Z Deng1, F Haghighi, L Helleby, K Vanterpool, E M Horn, R J Barst, S E Hodge, J H Morse, J A Knowles.   

Abstract

Familial primary pulmonary hypertension (PPH) is a rare autosomal dominant disease characterized by distinctive changes in pulmonary arterioles that lead to increased pulmonary artery pressures, right ventricular failure, and death. Our previous studies had mapped the disease locus, PPH1, to a 27-cM region on chromosome 2q31-q33, with a maximum multipoint logarithm of the odds favoring genetic linkage score of 3.87 with markers D2S350 and D2S364. To narrow the minimal genetic region for PPH, we physically mapped 33 highly polymorphic microsatellite markers and used them to genotype 44 affected individuals and 133 unaffected individuals from 17 families with PPH. We observed recombination events that substantially reduced the interval for PPH1 to the approximately 3-cM region that separates D2S311 and D2S1384. This entire region lies within chromosome 2q33. A maximum two-point lod score of 7.23 at a recombination fraction of zero was obtained for marker D2S307. A maximum multipoint lod score of 7.41 was observed close to marker D2S1367. The current minimal genetic region contains multiple candidate genes for PPH, including a locus thought to play a role in lung cancer.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10712363     DOI: 10.1164/ajrccm.161.3.9906051

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  22 in total

Review 1.  Primary pulmonary hypertension: the pressure rises for a gene.

Authors:  J R Thomson; R C Trembath
Journal:  J Clin Pathol       Date:  2000-12       Impact factor: 3.411

2.  Functional mutations in 5'UTR of the BMPR2 gene identified in Chinese families with pulmonary arterial hypertension.

Authors:  Jian Wang; Chenting Zhang; Chunli Liu; Wei Wang; Nuofu Zhang; Cyrus Hadadi; Junyi Huang; Nanshan Zhong; Wenju Lu
Journal:  Pulm Circ       Date:  2016-03       Impact factor: 3.017

3.  RNA Sequencing Analysis Detection of a Novel Pathway of Endothelial Dysfunction in Pulmonary Arterial Hypertension.

Authors:  Christopher J Rhodes; Hogune Im; Aiqin Cao; Jan K Hennigs; Lingli Wang; Silin Sa; Pin-I Chen; Nils P Nickel; Kazuya Miyagawa; Rachel K Hopper; Nancy F Tojais; Caiyun G Li; Mingxia Gu; Edda Spiekerkoetter; Zhaoying Xian; Rui Chen; Mingming Zhao; Mark Kaschwich; Patricia A Del Rosario; Daniel Bernstein; Roham T Zamanian; Joseph C Wu; Michael P Snyder; Marlene Rabinovitch
Journal:  Am J Respir Crit Care Med       Date:  2015-08-01       Impact factor: 21.405

Review 4.  The genetics of pulmonary arterial hypertension.

Authors:  Eric D Austin; James E Loyd
Journal:  Circ Res       Date:  2014-06-20       Impact factor: 17.367

Review 5.  The genetic basis of pulmonary arterial hypertension.

Authors:  Lijiang Ma; Wendy K Chung
Journal:  Hum Genet       Date:  2014-01-21       Impact factor: 4.132

6.  Familial primary pulmonary hypertension (gene PPH1) is caused by mutations in the bone morphogenetic protein receptor-II gene.

Authors:  Z Deng; J H Morse; S L Slager; N Cuervo; K J Moore; G Venetos; S Kalachikov; E Cayanis; S G Fischer; R J Barst; S E Hodge; J A Knowles
Journal:  Am J Hum Genet       Date:  2000-07-20       Impact factor: 11.025

7.  Neonatal hyperoxia causes pulmonary vascular disease and shortens life span in aging mice.

Authors:  Min Yee; R James White; Hani A Awad; Wendy A Bates; Sharon A McGrath-Morrow; Michael A O'Reilly
Journal:  Am J Pathol       Date:  2011-05-06       Impact factor: 4.307

8.  BMPR2 haploinsufficiency as the inherited molecular mechanism for primary pulmonary hypertension.

Authors:  R D Machado; M W Pauciulo; J R Thomson; K B Lane; N V Morgan; L Wheeler; J A Phillips; J Newman; D Williams; N Galiè; A Manes; K McNeil; M Yacoub; G Mikhail; P Rogers; P Corris; M Humbert; D Donnai; G Martensson; L Tranebjaerg; J E Loyd; R C Trembath; W C Nichols
Journal:  Am J Hum Genet       Date:  2000-12-12       Impact factor: 11.025

9.  Modulation of Endothelial Bone Morphogenetic Protein Receptor Type 2 Activity by Vascular Endothelial Growth Factor Receptor 3 in Pulmonary Arterial Hypertension.

Authors:  Cheol Hwangbo; Heon-Woo Lee; Hyeseon Kang; Hyekyung Ju; David S Wiley; Irinna Papangeli; Jinah Han; Jun-Dae Kim; William P Dunworth; Xiaoyue Hu; Seyoung Lee; Omar El-Hely; Avraham Sofer; Boryeong Pak; Laura Peterson; Suzy Comhair; Eun Mi Hwang; Jae-Yong Park; Jean-Leon Thomas; Victoria L Bautch; Serpil C Erzurum; Hyung J Chun; Suk-Won Jin
Journal:  Circulation       Date:  2017-03-29       Impact factor: 29.690

10.  Novel loci interacting epistatically with bone morphogenetic protein receptor 2 cause familial pulmonary arterial hypertension.

Authors:  Laura Rodriguez-Murillo; Ryan Subaran; William C L Stewart; Sreemanta Pramanik; Sudhir Marathe; Robyn J Barst; Wendy K Chung; David A Greenberg
Journal:  J Heart Lung Transplant       Date:  2009-10-28       Impact factor: 10.247

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.